Vaccination of mice with Salmonella expressing VapA: Mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Oliveira, Aline F ^a   Ruas, Luciana P ^a   Cardoso, Silvia A ^a   Soares, Sandro G ^a   Roque Barreira, Maria Cristina ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HYDROGEN PEROXIDE; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; MESSENGER RNA; NITRIC OXIDE; SALMONELLA TYPHIMURIUM VACCINE; SALMONELLOSIS VACCINE; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VAPA ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG MECHANISM; HUMORAL IMMUNITY; MOUSE; NONHUMAN; RHODOCOCCUS EQUI; SALMONELLA ENTERICA; SPLEEN CELL; TH1 CELL; TH2 CELL; VACCINATION;

ACTINOMYCETALES INFECTIONS; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BASE SEQUENCE; CELL PROLIFERATION; CYTOKINES; DNA PRIMERS; FLOW CYTOMETRY; GATA3 TRANSCRIPTION FACTOR; HYDROGEN PEROXIDE; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; MICE; MICE, INBRED BALB C; NITRIC OXIDE; POLYMERASE CHAIN REACTION; RHODOCOCCUS EQUI; SALMONELLA ENTERICA; T-BOX DOMAIN PROTEINS; TH1 CELLS;

MUS; RHODOCOCCUS EQUI; SALMONELLA; SALMONELLA ENTERICA;

EID: 77649264786     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008644     Document Type: Article

References (49)

1. Giguere S, Prescott JF (1997) Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals. Vet Microbiol 56: 313-334.
2. Donisi A, Suardi MG, Casari S, Longo M, Cadeo GP, et al. (1996) Rhodococcus equi infection in HIV-infected patients. AIDS 10: 359-362.
3. Meijer WG, Prescott JF (2004) Rhodococcus equi. Vet Res 35: 383-396.
4. Magnusson H (1923) Spezifische infektiose pneumonie beim Fohlen. Ein neuer eiterreger beim Pferd. Arch Wiss Prakt Tierhelkd 50: 22-38.
5. Hondalus MK (1997) Pathogenesis and virulence of Rhodococcus equi. Vet Microbiol 56: 257-268.
6. Takai S, Hines SA, Sekizaki T, Nicholson VM, Alperin DA, et al. (2000) DNA sequence and comparison of virulence plasmids from Rhodococcus equi ATCC33701 and 103. Infect Immun 68: 6840-6847.
7. Muscatello G, Leadon DP, Klayt M, Ocampo-Sosa A, Lewis DA, et al. (2007) Rhodococcus equi infection in foals: the science of 'rattles'. Equine Vet J 39: 470-478.
8. Takai S, Iie M, Watanabe Y, Tsubaki S, Sekizaki T (1992) Virulence-associated 15- to 17-kilodalton antigens in Rhodococcus equi: temperature dependent expression and location of the antigens. Infect Immun 60: 2995-2997.
9. Giguère S, Hondalus MK, Yager JA, Darrah P, Mosser DM, et al. (1999) Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi. Infect Immun 67: 3548-3557.
10. Jain S, Bloom BR, Hondalus MK (2003) Deletion of vapA encoding Virulence Associated Protein A attenuates the intracellular actinomycete R. equi. Mol Microbiol 50: 115-128.
11. Prescott JF, Patterson MC, Nicholson VM, Morein B, Yager JA (1997) Assessment of the immunogenic potential of Rhodococcus equi virulence associated protein (VapA) in mice. Vet Microbiol 56: 213-225.
12. Hooper-McGrevy KE, Giguere S, Wilkie BN, Prescott JF (2001) Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia. Am J Vet Res 62: 1307-1313.
13. Martens RJ, Martens JG, Fiske RA, Hietala SK (1989) Rhodococcus equi foal pneumonia: protective effects of immune plasma in experimentally infected foals. Equine Vet J 21: 249-255.
14. Hines SA, Kanaly ST, Byrne BA, Palmer GH (1997) Immunity to Rhodococcus equi. Vet Microbiol 56: 177-185.
15. Hurley JR, Begg AP (1995) Failure of hyperimmune plasma to prevent pneumonia caused by Rhodococcus equi in foals. Aust Vet J 72: 418-420.
16. Giguere S, Gaskin JM, Bowman JL (2002) Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals. J Am Vet Med Assoc 220: 59-63.
17. + T lymphocytes. Clin Diagn Lab Immunol 10: 208-215.
18. Kanaly ST, Hines SA, Palmer GH (1995) Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infect Immun 63: 3037-3041.
19. Kanaly ST, Hines SA, Palmer GH (1996) Transfer of a CD4+ Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung. Infect Immun 64: 1126-1132.
20. Dietrich G, Kolb-Mäurer A, Spreng S, Schartl M, Goebel W, et al. (2001) Gram-positive and Gram-negative bacteria as carrier systems for DNA vaccines. Vaccine 19: 2506-2512.
21. Du A, Wang S (2005) Efficacy of a DNA vaccine delivered in attenuated Salmonella Typhimurium against Eimeria tenella infection in chickens. Int J Parasitol 35: 777-785.
22. Pasetti MF, Levine MM, Sztein MB (2003) Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors. Vaccine 21: 401-418.
23. Kotton CN, Hohmann EL (2004) Enteric pathogens as vaccine vectors for foreign antigen delivery. Infect Immun 72: 5535-5547.
24. Wyszynska A, Raczko A, Lis M, Jagusztyn-krynicka EK (2004) Oral immunization of chickens with avirulent Salmonella vaccine strain carrying C. jejuni 72Dz/92 cjaA gene elicits specific humoral immune response associated with protection against challenge with wild-type Campylobacter. Vaccine 22: 1379-1389.
25. Shiau AL, Chen CC, Yo YT, Chu CY, Wang SY, et al. (2005) Enhancement of humoral and cellular immune responses by an oral Salmonella choleraesuis vaccine expressing porcine prothymosin alpha. Vaccine 23: 5563-5571.
26. Yang X, Hinnebusch BJ, Trunkle T, Bosio CM, Suo Z, et al. (2007) Oral vaccination with Salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J Immunol 178: 1059-1067.
27. Oliveira AF, Ferraz LC, Brocchi M, Roque-Barreira MC (2007) Oral administration of a live attenuated Salmonella vaccine strain expressing the VapA protein induces protection against infection by Rhodococcus equi. Microbes Infect 9: 382-390.
28. rd R, Kelly SM (1987) Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect Immun 55: 3035-3043.
29. Pick E, Mizel D (1981) Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods 46: 211-226.
30. Hochadel JF, Keller KF (1977) Protective effects of passively transferred immune T- or B-lymphocytes in mice infected with Salmonella Typhimurium. J Infect Dis 135: 813-823.
31. Lopez AM, Hines MT, Palmer GH, Knowles DP, Alperin DC, et al. (2003) Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA of Rhodococcus equi. Vaccine 21: 3815-3825.
32. Yager JA, Prescott CA, Kramar DP, Hannah H, Balson GA, et al. (1991) The effect of experimental infection with Rhodococcus equi on immunodeficient mice. Vet Microbiol 28: 363-376.
33. Kanaly ST, Hines SA, Palmer GH (1993) Failure of pulmonary clearance of Rhodococcus equi infection in CD4+ T-lymphocyte-Deficient transgenic mice. Infect Immun 61: 4929-4932.
34. Cong H, Gu QM, Jiang Y, He SY, Zhou HY, et al. (2005) Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii. Parasite Immunol 27: 29-35.
35. Breathnach CC, Sturgill-Wright T, Stiltner JL, Adams AA, Lunn DP, et al. (2006) Foals are interferon gamma-deficient at birth. Vet Immunol Immunopathol 112: 199-209.
36. Kasuga-Aoki H, Takai S, Sasaki Y, Tsubaki S, Madarame H, et al. (1999) Tumor necrosis factor and interferon-γ are required in host resistance against virulent Rhodococcus equi infection in mice: cytokine production depends on the virulence levels of R.equi. Immunol 96: 122-127.
37. Darrah PA, Hondalus MK, Chen Q, Ischiropoulos H, Mosser DM (2000) Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect Immun 68: 3587-3593.
38. Criscione LG, St Clair EW (2002) Tumor necrosis factor-α antagonists for the treatment of rheumatic diseases. Curr Opin Rheumatol 14: 204-211.
39. Abuzakouk M, Feighery C, Jackson J (2002) Tumor necrosis factor blocking agents: a new therapeutic modality for inflammatory disorders. Br J Biomed Sci 59: 173-179.
40. Dong C, Flavell RA (2000) Control of T helper cell differentiation - in search of master genes. Science's stke 49: 1-5.
41. Madigan EJ, Hietala S, Muller SN (1991) Protection against naturally acquired Rhodococcus equi pneumonia in foals by administration of hyperimmune plasma. J Reprod Fertil Suppl 44: 571-578.
42. Nordmann P, Ronco E, Nauciel C (1992) Role of T-lymphocyte subsets in Rhodococcus equi infection. Infect Immun 60: 2748-2752.
43. Patton KM, McGuire TC, Fraser DG, Hines SA (2004) Rhodococcus equi-infected macrophages are recognized and killed by CD8+ T lymphocytes in a major histocompatibility complex class I-unrestricted fashion. Infect Immun 72: 7073-7083.
44. Mastroeni P, Villarreal-Ramos B, Hormaeche CE (1992) Role of T cells TNF-α and IFN-γ in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro-Salmonella vaccines. Microb Pathog 13: 477-491.
45. Li MO, Wan YY, Flavell RA (2007) T cell-produced Transforming Growth Factor-b1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26: 579-591.
46. Anderson CF , Oukka M, Kuchroo VJ , Sacks D (2007 ) CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. Anderson J Exp Med 204: 285-297.
47. Jankovic D, Kullberg MC, Feng CG, Goldszmid RS, Collazo CM, et al. Conventional Tbet(+) Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204: 273-283.
48. Moore KW, O'Garra A, De Waal MR, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Ver Immunol 11: 165-190.
49. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, et al. (2006) Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212: 28-50.